These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
640 related items for PubMed ID: 9393761
1. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents. Kokkinakis DM, Ahmed MM, Delgado R, Fruitwala MM, Mohiuddin M, Albores-Saavedra J. Cancer Res; 1997 Dec 01; 57(23):5360-8. PubMed ID: 9393761 [Abstract] [Full Text] [Related]
2. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine. Kokkinakis DM, Ahmed MM, Chendil D, Moschel RC, Pegg AE. Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3801-7. PubMed ID: 14506174 [Abstract] [Full Text] [Related]
3. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU. Schold SC, Kokkinakis DM, Rudy JL, Moschel RC, Pegg AE. Cancer Res; 1996 May 01; 56(9):2076-81. PubMed ID: 8616853 [Abstract] [Full Text] [Related]
4. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy. Silber JR, Blank A, Bobola MS, Ghatan S, Kolstoe DD, Berger MS. Clin Cancer Res; 1999 Apr 01; 5(4):807-14. PubMed ID: 10213216 [Abstract] [Full Text] [Related]
7. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents. Srivenugopal KS, Shou J, Mullapudi SR, Lang FF, Rao JS, Ali-Osman F. Clin Cancer Res; 2001 May 01; 7(5):1398-409. PubMed ID: 11350911 [Abstract] [Full Text] [Related]
8. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines. Bobola MS, Silber JR, Ellenbogen RG, Geyer JR, Blank A, Goff RD. Clin Cancer Res; 2005 Apr 01; 11(7):2747-55. PubMed ID: 15814657 [Abstract] [Full Text] [Related]
12. Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosourea. Kokkinakis DM, Moschel RC, Pegg AE, Schold SC. Clin Cancer Res; 1999 Nov 01; 5(11):3676-81. PubMed ID: 10589786 [Abstract] [Full Text] [Related]
16. Cellular resistance against the novel hybrid anthracycline N-(2-chloroethyl)-N-nitrosoureidodaunorubicin (AD 312) is mediated by combined altered topoisomerase II and O6-methylguanine-DNA methyltransferase activities. Pawlik CA, Israel M, Sweatman TW, Lothstein L. Oncol Res; 1998 Nov 01; 10(4):209-17. PubMed ID: 9778692 [Abstract] [Full Text] [Related]
17. DNA repair enzyme, O6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors. Kuo CC, Liu JF, Chang JY. J Pharmacol Exp Ther; 2006 Feb 01; 316(2):946-54. PubMed ID: 16258022 [Abstract] [Full Text] [Related]
18. Evaluation of O6-methylguanine DNA methyltransferase activity in patients with gastric cancer. Dinçer Y, Akçay T, Tortum OB, Alademir Z, Onen S, Doğusoy G. Oncol Res; 2003 Feb 01; 13(4):205-9. PubMed ID: 12659421 [Abstract] [Full Text] [Related]
19. Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines. Jean-Claude BJ, Mustafa A, Watson AJ, Damian Z, Vasilescu D, Chan TH, Leyland-Jones B. J Pharmacol Exp Ther; 1999 Feb 01; 288(2):484-9. PubMed ID: 9918549 [Abstract] [Full Text] [Related]
20. Collateral sensitivity to nitrosoureas in multidrug-resistant cells selected with verapamil. Futscher BW, Campbell K, Dalton WS. Cancer Res; 1992 Sep 15; 52(18):5013-7. PubMed ID: 1387586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]